Technical Analysis for WXIBF - Wuxi Biologics Cayman Inc

Grade Last Price % Change Price Change
grade B 10.65 15.76% 1.4500
WXIBF closed up 15.76 percent on Monday, September 9, 2019, on 5 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Up
See historical WXIBF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Narrow Range Bar Range Contraction 15.76%
Gapped Down Weakness 15.76%
Narrow Range Bar Range Contraction 10.19%
Gapped Up Strength 10.19%
Hot IPO Pullback Bullish Swing Setup 10.71%
Narrow Range Bar Range Contraction 10.71%
Inside Day Range Contraction 10.71%

Older signals for WXIBF ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
WuXi Biologics (Cayman) Inc., an investment holding company, provides discovery, research, development, and manufacturing of biologics services. It offers clinical and commercial manufacturing, assay, formulation and process development, assay and process validation, protein, monoclonal antibodies and cGMP drug substances manufacturing, lot release testing, stability studies, drug product formulation, fill and finish, and regulatory support services. The company also provides consultation services for biopharmaceutical technology, sales and marketing, and international sales contracting service; and produces and sells medicals. It serves pharmaceutical and biotechnology companies. WuXi Biologics (Cayman) Inc. has a strategic collaboration with Bioasis Technologies Inc. to develop and manufacture xB3-001 to treat cancer; CANbridge Pharmaceutical Inc. to develop and commercialize a portfolio of iotherapeutics for the treatment of rare diseases; ABL Bio Corporation to develop bispecific antibodies; AC Immune SA for biologics discovery, development, and manufacturing; Oxford BioTherapeutics for developing bispecific antibodies; and Amicus Therapeutics, Inc. The company was founded in 2014 and is headquartered in Wuxi, China. WuXi Biologics (Cayman) Inc. is a subsidiary of WuXi Biologics Holdings Limited.
Manufacturing Biotechnology Cancer Nature Biopharmaceutical Biology Antibodies Consultation Services Rare Diseases Monoclonal Antibody
Is WXIBF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 10.9948
52 Week Low 6.2
Average Volume 3,738
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 9.2139
10-Day Moving Average 9.9927
Average True Range 0.8056
ADX 0.0
+DI 52.5904
-DI 44.4108
Chandelier Exit (Long, 3 ATRs ) 8.578
Chandelier Exit (Short, 3 ATRs ) 8.6168
Upper Bollinger Band 11.9206
Lower Bollinger Band 6.5072
Percent B (%b) 0.77
BandWidth 58.752537
MACD Line 0.4484
MACD Signal Line 0.3406
MACD Histogram 0.1079
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.6500
Resistance 3 (R3) 10.6500 10.6500 10.6500
Resistance 2 (R2) 10.6500 10.6500 10.6500 10.6500
Resistance 1 (R1) 10.6500 10.6500 10.6500 10.6500 10.6500
Pivot Point 10.6500 10.6500 10.6500 10.6500 10.6500
Support 1 (S1) 10.6500 10.6500 10.6500 10.6500 10.6500
Support 2 (S2) 10.6500 10.6500 10.6500 10.6500
Support 3 (S3) 10.6500 10.6500 10.6500
Support 4 (S4) 10.6500